NLRP3 and Hepatitis: As mentioned previously, rhIL-1RAs reduce the severity of ConA-induced hepatitis by eliminating ROS, inhibiting NLRP3 inflammasome assembly and activation, preventing pyroptosis, and competing with IL-1β (Wang et al., 2016a).